Exhibit 99.1
HEARUSA REPORTS FISCAL 2005 RESULTS
| • | Net Revenues Increase 11.5% to $76.7 million |
| • | Net Loss Per Share Applicable to Common Stockholders Narrows to Six Cents |
| • | Income from Operations Grows by 58% to $3.7 million |
West Palm Beach, Florida April 3, 2006 – HearUSA, Inc. (AMEX: EAR) reported today that net revenues for its fiscal year ended December 31, 2005 rose by 11.5% to $76.7 million from $68.7 million the previous year. The increase in net revenues is the result of higher average selling prices as well as an increase in the number of hearing aids sold. In addition, 2005 included an additional week of operations which occurred in the first quarter of 2005.
Income from operations for fiscal 2005 grew to $3.7 million up 58% from $2.3 million a year earlier. The Company’s net loss applicable to common stockholders narrowed to $1.8 million or six cents per share, from $3.5 million, or ten cents per share the year before. The Company noted that results for fiscal 2005 included a non-cash charge of approximately $2.5 million related to the non-cash debt discount amortization from financings as compared to a non-cash debt discount amortization charge of $2.1 million in 2004.
Stephen J. Hansbrough, Chief Executive Officer and President stated, “We are pleased with the results of 2005. The Company reached a number of important milestones, including record revenues, improved profitability from operations and tactical divestitures and selective acquisitions of hearing centers. During the last six months of 2005, we added five stand-alone clinics and two clinics which were rolled into existing company-owned locations. The acquired clinics contributed $1.3 million of revenues during the period they were part of HearUSA. Since early 2006 revenues have significantly improved from early 2005, it appears fourth quarter revenues, which were below our expectations, were primarily a result of a variation in patient spending patterns. The fourth quarter was also adversely affected by our call center being closed for a week after Hurricane Wilma.”
Commenting on expense control, Hansbrough stated, “It is worth noting that our program to control costs is having the desired effect. Operating expenses in 2005, although higher, rose at a slower rate than revenues. Total operating costs and expenses rose 9.8% from $66.4 million in 2004 to $73 million in 2005.”
Cost of products sold and services increased by 18% to $22.8 million from $19.2 million the previous year. The increase is due to a combination of higher sales volume and a shift in the company’s sales mix as a larger percentage of hearing aids sold were advanced technology units which carry a higher cost to the company but also a higher selling price. Included in the cost of hearing aids and other products are the Siemens preferred pricing reductions of approximately $3.3 million in 2005 and $3.6 million in 2004. These pricing reductions, a product of the company’s supply and credit agreements with Siemens, are accounted for as reductions of cost of products sold and applied against certain of the principal and interest payments due Siemens under the credit agreement.
Center operating expenses in 2005 were $36.6 million, an increase of 4.7% from $34.9 million a year earlier. The additional week included in fiscal 2005, higher incentive compensation and normal merit increases in wages were factors contributing to the increase. Also contributing to the increase was the impact of approximately $435,000 of operating costs related to centers acquired in the final six months of 2005.
General and administrative costs rose in 2005 by $1.4 million or 14.1% to $11.7 million from $10.2 million. Wages and other expenses related to the Company’s newly created Sales and Acquisition departments accounted for the bulk of the increase.
Paul A. Brown, M.D., Founder and Chairman stated, “With the actions we took in 2005, we are in an excellent position to grow the company in 2006 and beyond. We are more focused in terms of our markets and have an experienced management team in place to execute our growth strategy. The demographic profile of the nation’s population is such that demand for hearing assistance products should continue to expand. Our financial condition is stronger than it was at the start of 2005. Just after year end we concluded a modified and extended revolving credit agreement and supply agreement with Siemens, giving us the ability to pursue other acquisition opportunities.”
“With these and other elements in place, we have set a target for annual revenue growth of 15%-20%, divided equally between organic growth and acquisitions. This would produce revenues in 2006 of approximately $90 million, given normal business conditions and no disruptions similar to those we experienced in the last quarter of 2005,” Dr. Brown concluded.
About HearUSA
HearUSA provides hearing care to patients whose health insurance and managed care organizations have contracted with the company for such care and to retail self-pay patients. HearUSA centers, all of which are company owned, are located in California, Florida, New York, New Jersey, Massachusetts, Ohio, Michigan, and Missouri and the province of Ontario Canada. In addition, the company has a network of 1,400 affiliated audiologists in 49 states. For further information, click on “investor information” at HearUSA’s website www.hearusa.com.
This press release contains forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995, including those concerning the Company’s expectation that revenues for 2006 will be approximately $90 million. This statement involves certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statement. Potential risks and uncertainties include such factors as market demand for the Company’s goods and services; successful implementation of the Company’s acquisition program; changes in the pricing environment; general economic conditions in those geographic regions where the Company’s centers are located; the impact of competitive products; and other risks and uncertainties described in the Company’s filings with the Securities and Exchange Commission, including the Company’s annual report on Form 10-K for the 2005 fiscal year.
HearUSA will hold a webcast on Tuesday, April 4, 2006 at 4:15 P.M. Eastern Time to allow securities analysts and shareholders the opportunity to hear management discuss the results of the 2005 fiscal year and revenues for the first quarter of 2006. The call is being webcast by Vcall and can be accessed at HearUSA’s website at www.hearusa.com or investors can access the webcast at www.investorcalendar.com. The conference can also be listened to by telephone by dialing (toll free) 877-407-9210. The webcast will be available for replay through 5/4/06.
HearUSA, Inc.
Consolidated Balance Sheets
| December 31, | December 25, |
ASSETS | 2005 | 2004 |
Current assets |
|
|
Cash and cash equivalents | $ 6,706,944 | $ 2,615,379 |
Restricted Cash and cash equivalents | 431,000 | 435,000 |
Accounts and notes receivable, less allowance for |
|
|
Inventories | 1,604,943 | 801,234 |
Prepaid expenses and other | 1,627,407 | 557,435 |
Current assets held for sale | - | 77,458 |
Total current assets | 17,086,227 | 10,483,751 |
Property and equipment, net | 3,474,381 | 3,346,788 |
Goodwill | 36,394,959 | 33,210,380 |
Intangible assets, net | 11,440,345 | 11,094,169 |
Deposits and other | 585,633 | 551,148 |
Long-term assets held for sale | - | 736,125 |
| $ 68,981,545 | $ 59,422,361 |
| ||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
Current liabilities |
|
|
Accounts payable | $ 8,499,812 | $ 6,644,600 |
Accrued expenses | 2,344,419 | 2,424,147 |
Accrued salaries and other compensation | 2,589,877 | 1,982,559 |
Current maturities of long-term debt | 5,192,108 | 4,152,908 |
Current maturities of convertible subordinated notes, net of debt discount of | 652,147 | - |
Current maturities of subordinated notes, net of debt discount of $868,345 | 891,655 | - |
Dividends payable | 34,562 | 177,996 |
Total current liabilities | 20,204,580 | 15,382,210 |
Long-term debt | 19,970,099 | 17,296,125 |
Convertible subordinated notes, net of debt discount of $1,565,187 and | 3,434,813 | 2,056,121 |
Subordinated notes, net of debt discount of $512,350 | 2,787,650 | - |
Warrant Liability | 1,869,360 | - |
Total long-term debt and convertible subordinated notes | 28,061,922 | 19,352,246 |
Commitments and contingencies | - | - |
Mandatorily redeemable convertible preferred stock | - | 4,709,921 |
|
|
|
Stockholders’ equity |
|
|
Preferred stock (aggregate liquidation preference $2,330,000 and |
|
|
Series H Junior Participating (none outstanding) | - | - |
Series J (233 shares outstanding) | 233 | 233 |
Total preferred stock | 233 | 233 |
|
|
|
Common stock: $0.10 par; 50,000,000 shares authorized 30,060,690 | 3,189,320 | 3,006,069 |
Stock subscription | (412,500) | (412,500) |
Additional paid-in capital | 121,934,658 | 120,197,937 |
Accumulated deficit | (103,774,422) | (101,968,452) |
Accumulated other comprehensive income | 2,262,895 | 1,639,838 |
Treasury stock, at cost: 523,662 common shares | (2,485,141) | (2,485,141) |
Total stockholders’ equity | 20,715,043 | 19,977,984 |
| $ 68,981,545 | $ 59,422,361 |
HearUSA, Inc.
Consolidated States of Operations
| Year Ended | ||
| December 31, | December 25, | December 27, |
| 2005 | 2004 | 2003 |
|
|
|
|
Net revenues |
|
|
|
Hearing aids and other products | $ 71,445,381 | $ 63,227,755 | $ 60,927,044 |
Services | 5,226,622 | 5,521,767 | 6,153,064 |
Total net revenues | 76,672,003 | 68,749,542 | 67,080,108 |
|
|
|
|
Operating costs and expenses |
|
|
|
Hearing aids and other products | 20,972,635 | 17,511,405 | 18,836,929 |
Services | 1,793,944 | 1,718,287 | 128,759 |
Total cost of products sold and services | 22,766,579 | 19,229,692 | 18,965,688 |
Center operating expenses | 36,555,590 | 34,890,950 | 32,591,897 |
General and administrative expenses | 11,660,725 | 10,218,283 | 10,470,717 |
Depreciation and amortization | 1,974,193 | 2,072,237 | 2,783,877 |
Total operating costs and expenses | 72,957,087 | 66,411,162 | 64,812,179 |
Income from operations | 3,714,916 | 2,338,380 | 2,267,929 |
Non-operating income (expense): |
|
|
|
Gain from insurance proceeds | 430,122 | - | - |
Interest income | 53,921 | 17,543 | 20,836 |
Interest expense (including approximately | (5,162,701) | (4,563,729) | (2,828,327) |
Loss from continuing operations before income | (963,742) | (2,207,806) | (539,562) |
|
|
|
|
Income taxes | (78,000) | - | - |
Net loss from continuing operations | (1,041,742) | (2,207,806) | (539,562) |
|
|
|
|
Discontinued operations |
|
|
|
Gain on disposition of assets | 332,470 | - | - |
Loss from discontinued operations | (396,023) | (550,696) | (569,827) |
Net loss from discontinued operations | (63,553) | (550,696) | (569,827) |
|
|
|
|
Net loss | (1,105,295) | (2,758,502) | (1,109,389) |
|
|
|
|
Dividends on preferred stock | (700,675) | (708,159) | (626,956) |
Net loss applicable to common stockholders | $ (1,805,970) | $ (3,466,661) | $ (1,736,345) |
|
|
|
|
Net loss from continuing operations, including | $ (0.06) | $ (0.10) | $ (0.04) |
Net loss applicable to common stockholders per | $ (0.06) | $ (0.11) | $ (0.06) |
|
|
|
|
Weighted average number of shares of | 31,610,793 | 30,426,829 | 30,424,262 |
|
|
|
|